A Public Citizen report obtained exclusively by NPR shows the new administration has halted or tried to dismiss cases or ...
Q4 2024 Earnings Call Transcript March 3, 2025 Greg McNiff: Welcome everyone to Exodus’ Fourth Quarter 2024 Earnings Conference Call. I’m your host, Greg McNiff, and joining us today are Exodus ...
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback